-
41
Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatment...
Published 2024-02-01Subjects: “…breakthrough SARS-CoV-2 infection, multiple myeloma, serological response…”
Get full text
Article -
42
More than meets the eye: Nocardia farcinica, Candida dubliniensis and Aspergillus spp. co-infection in a patient with multiple myeloma treated with multiple treatment regimens
Published 2025-02-01Subjects: “…Multiple myeloma…”
Get full text
Article -
43
Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftme...
Published 2024-04-01Subjects: “…Multiple myeloma…”
Get full text
Article -
44
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
Published 2025-01-01Subjects: Get full text
Article -
45
GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFβ signaling pathway
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
46
Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
Published 2025-02-01Subjects: “…Multiple myeloma…”
Get full text
Article -
47
Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
48
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
Published 2025-02-01Subjects: Get full text
Article -
49
Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
Published 2020-04-01Subjects: “…multiple myeloma…”
Get full text
Article -
50
Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
Published 2024-04-01Subjects: Get full text
Article -
51
Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
52
Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma
Published 2025-01-01Subjects: Get full text
Article -
53
Serum free light-chain concentration and relationship with some characteristics of patients with multiple myeloma
Published 2023-01-01Subjects: “…multiple myeloma…”
Get full text
Article -
54
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram
Published 2025-01-01Subjects: “…multiple myeloma…”
Get full text
Article -
55
-
56
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Published 2024-09-01Subjects: Get full text
Article -
57
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
Published 2021-07-01Subjects: “…multiple myeloma…”
Get full text
Article -
58
Long-term trends in the burden of multiple myeloma in China: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
59
5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
Published 2024-12-01Subjects: Get full text
Article -
60
Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
Published 2025-01-01Subjects: Get full text
Article